Preparation of (8S)-8-Fluoroerythronolide A (cas 104160-68-1) and (8S)-8-fluoroerythronolide B, potential substrates for the biological synthesis of new macrolide antibiotics

Add time:08/01/2019    Source:sciencedirect.com

Synthetic studies are reported in the erythromycin analogue area. Reaction of trifluoromethyl hypofluorite (CF3OF) with 8,9-anhydroerythronolide A 6,9-hemiketal (1) or 8,9-anhydroerythronolide B 6,9-hemiketal (2) afforded, as major product, (8S)-8-fluoroerythronolide A 6,9;9,ll-spiroketal (3) or (8S)-8-fluoroerythronolide B 6,9;9,ll-spiroketal (4) and, as minor product, (8S)-8-fluoroerythronolide A (5) or (8S)-8-fluoroerythronolide B (6). Hydrolysis of 3 in boiling aqueous acetic acid gave 5, 9,10-anhydro-(8S)-8-fluoroerythronolide A 6,9-hemiketal (7), (8S)-8-fluoroerythronolide A 5,9;9,12-spiroketal (9) and 5,8-epoxy-8-epi-erythronolide A (10). Analogous range of products was obtained by acid hydrolysis of 4

We also recommend Trading Suppliers and Manufacturers of 8-Fluoroerythronolide A (cas 104160-68-1). Pls Click Website Link as below: cas 104160-68-1 suppliers

Prev:Analysis of stereoelectronic properties of camptothecin analogues in relation to biological activity
Next:Transformation of 3-0-mycarosylerythronolide B, an intermediate of erythromycin biogenesis, into 3-0-mycarosyl-(8S)-8-fluoroerythronolide B using trifluoromethyl hypofluorite)